Come up with a name for your new list and we'll add to it:
Altor BioScience raised a round of funding on May 06, 2011. Investors include
National Heart Lung and Blood Institute.
Altor BioScience is a biopharmaceutical company engaged in the discovery, development and commercialization of high-value, targeted immunotherapeutic agents for the treatment of cancer, viral infectio…